Search Results 1611-1620 of 18702 for autoimmune hepatitis

  1. Clostridium difficile Archives - Mayo Clinic News Network

    Microbiome Role in Cancer, IBD, Obesity, and Infections. This is a companion to the story, Recruiting Microbes to Fight Autoimmune Diseases Researchers in ...

  2. LS1681: A Study of AR160 in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility · History of liver disease such as cirrhosis, chronic active hepatitis, chronic persistent hepatitis or hepatitis B or C. · Active ...

  3. Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma - Mayo Clinic

    Active hepatitis B virus (HBV) infection, defined as having a positive hepatitis B surface antigen (HBsAg) test at screening. ... Active or history of autoimmune ...

  4. Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) - Mayo Clinic

    History of interstitial lung disease, prior malignancy, active autoimmune disease, positive test for hepatitis B or hepatitis C virus; Prior allogeneic stem ...

  5. Therapies for hepatitis C - Liver Transplant

    Mayo Clinic's Liver Transplant Program offers expert liver transplantation and comprehensive specialty treatment for people with serious liver disease.

  6. A Study to Evaluate the Effectiveness and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis - Mayo Clinic

    The subject has a known liver disease or is positive for hepatitis B or C. For hepatitis B/C, the subject has 1 of the following at screening: Chronic hepatitis ...

  7. Center for Clinical and Translational Science - Center for Clinical and Translational Science (CCaTS)

    Disparities in Liver Disease Among Immigrants in Minnesota. Undergraduate. B.A., St. Olaf College, Northfield, Minnesota. More about research at Mayo Clinic.

  8. Publications - Eric C. Ehman, M.D. - Mayo Clinic

    CT of hepatocellular carcinoma in non-alcoholic fatty liver disease: imaging characteristics and inter-rater agreement Hepatoma Research. 2019; 5(39) ...

  9. Panobinostat and Everolimus in Treating Patients with Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma - Mayo Clinic

    ... liver disease such as cirrhosis, chronic hepatitis or chronic persistent hepatitis, or uncontrolled infections will be excluded; Known hypersensitivity to ...

  10. A Study to Evaluate Pemetrexed and Pembrolizumab to Treat Recurrent and/or Metastatic Salivary Gland Malignancies - Mayo Clinic

    Active autoimmune disease requiring systemic treatment < 2 years prior to ... Known history of hepatitis B (i.e., known positive HBV surface antigen (HBsAg) ...